Replies to post #7671 on Halozyme Therapeutics Inc (HALO)

[biotechinvestor1]

I agree with your perspective. Please write to Halo IR and share your views as I have.

Once we have the new deals (any day now), Helen needs to go on CNBC/bloomberg and get the attention of retail investors.

Once she does, the following bargain numbers will be history. In the meantime, I’m buying every week and won’t be distracted by the noise from the naysayers who ignore the following facts:

Price/Earnings Ratio
2022 Actual 18.86
2023 Estimates 15.81
2024 Estimates 10.96
2025 Estimates 9.06

Forecast P/E Growth Rates
Growth 2023 19.23
Growth 2024 44.15
P/E Ratios 2023 15.81
P/E Ratios 2024 10.96

PEG Ratio
Forecast 12 Month Forward PEG Ratio 0.61

Source: https://www.nasdaq.com/market-activity/stocks/halo/price-earnings-peg-ratios